Evotec SE (EVOTF) Long-Term Deferred Tax (2020 - 2026)
Evotec SE's (EVOTF) quarterly Long-Term Deferred Tax came in at $1973.9 in Q1 2026, down 88.53% year-on-year from $17213.0 in Q1 2025, and down 42.5% quarter-over-quarter from $3432.8 in Q4 2025.
Evotec SE (EVOTF) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Long-Term Deferred Tax across 7 years of filings, most recently posting $1973.9 for Q1 2026.
- Long-Term Deferred Tax for Q1 2026 came in at $1973.9, down 88.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $1973.9 (down 88.53% YoY), and the FY2025 annual result was $3432.8, down 99.98% from the prior year.
- Long-Term Deferred Tax came in at $1973.9 for Q1 2026 at Evotec SE, down from $3432.8 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $65.5 million in Q4 2023 to a low of $1973.9 in Q1 2026.
- The 5-year median for Long-Term Deferred Tax is $18536.3 (2022), against an average of $7.9 million.
- Across the five-year window, Long-Term Deferred Tax surged 522.06% in 2023 and plunged 99.98% in 2025, its largest moves.
- Evotec SE's Long-Term Deferred Tax stood at $10.5 million in 2022, then soared by 522.06% to $65.5 million in 2023, then tumbled by 71.74% to $18.5 million in 2024, then slumped by 99.98% to $3432.8 in 2025, then slumped by 42.5% to $1973.9 in 2026.
- The last three Long-Term Deferred Tax figures came in at $1973.9 (Q1 2026), $3432.8 (Q4 2025), and $13002.2 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Evotec SE | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,973.88 |
| Dec 31, 2025 | 3,432.76 |
| Sep 30, 2025 | 13,002.23 |
| Jun 30, 2025 | 18,818.83 |
| Mar 31, 2025 | 17,213.04 |
| Dec 31, 2024 | 18.52 Mn |
| Sep 30, 2024 | 39,595.21 |
| Mar 31, 2024 | 23,708.76 |
| Dec 31, 2023 | 65.54 Mn |
| Dec 31, 2022 | 10.54 Mn |
| Sep 30, 2022 | 16,171.71 |
| Mar 31, 2022 | 18,253.70 |
| Dec 31, 2021 | 66.88 Mn |
| Sep 30, 2021 | 29,147.27 |
| Dec 31, 2020 | -665,297.74 |